243 related articles for article (PubMed ID: 22784549)
1. ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma.
Grimm M; Krimmel M; Polligkeit J; Alexander D; Munz A; Kluba S; Keutel C; Hoffmann J; Reinert S; Hoefert S
Eur J Cancer; 2012 Nov; 48(17):3186-97. PubMed ID: 22784549
[TBL] [Abstract][Full Text] [Related]
2. Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells?
Grimm M; Shokri B; Alexander D; Munz A; Hoffmann J; Reinert S
Target Oncol; 2013 Sep; 8(3):189-201. PubMed ID: 23314953
[TBL] [Abstract][Full Text] [Related]
3. Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma.
Grimm M; Alexander D; Munz A; Hoffmann J; Reinert S
Clin Exp Metastasis; 2013 Apr; 30(4):529-40. PubMed ID: 23184277
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of Helicobacter pylori without association of TLR5 expression in oral squamous cell carcinoma.
Grimm M; Munz A; Exarchou A; Polligkeit J; Reinert S
J Oral Pathol Med; 2014 Jan; 43(1):35-44. PubMed ID: 23659788
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of CD44+/RANKL+ tumor cells in the carcinogenesis of oral squamous cell carcinoma.
Grimm M; Renz C; Munz A; Hoefert S; Krimmel M; Reinert S
Odontology; 2015 Jan; 103(1):36-49. PubMed ID: 23979059
[TBL] [Abstract][Full Text] [Related]
6. The human multidrug resistance gene (MDR-1): immunocytochemical detection of its expression in oral SCC.
Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Serpico R; Rubini C; Fioroni M; Fanali S; Piattelli A
Anticancer Res; 2000; 20(5A):2891-7. PubMed ID: 11062698
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis resistance-related ABCB5 and DNaseX (Apo10) expression in oral carcinogenesis.
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Reinert S
Acta Odontol Scand; 2015 Jul; 73(5):336-42. PubMed ID: 25234444
[TBL] [Abstract][Full Text] [Related]
8. Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma.
Friedrich RE; Punke C; Reymann A
In Vivo; 2004; 18(2):133-47. PubMed ID: 15113040
[TBL] [Abstract][Full Text] [Related]
9. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell immunophenotypes in oral squamous cell carcinoma.
Oliveira LR; Oliveira-Costa JP; Araujo IM; Soave DF; Zanetti JS; Soares FA; Zucoloto S; Ribeiro-Silva A
J Oral Pathol Med; 2011 Feb; 40(2):135-42. PubMed ID: 21073537
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
13. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Cathepsin B in oral squamous cell carcinoma.
Yang X; Wei KJ; Zhang L; Pan HY; Li J; Chen WT; Zhong LP; Zhang ZY
Int J Oral Maxillofac Surg; 2010 Feb; 39(2):174-81. PubMed ID: 20042316
[TBL] [Abstract][Full Text] [Related]
15. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines.
Felthaus O; Ettl T; Gosau M; Driemel O; Brockhoff G; Reck A; Zeitler K; Hautmann M; Reichert TE; Schmalz G; Morsczeck C
Biochem Biophys Res Commun; 2011 Apr; 407(1):28-33. PubMed ID: 21342656
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of Annexin A2 in oral squamous cell carcinoma.
Zhong LP; Wei KJ; Yang X; Zhang L; Zhou XJ; Pan HY; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2009 Jan; 54(1):17-25. PubMed ID: 18822406
[TBL] [Abstract][Full Text] [Related]
20. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]